Hollsteen
← Ciena

Research and development

Flow – sum over the period · $M

QuartersFiscal years

$MResearch and development · Q1 FY2016: $108M · 10-Q 0000936395-16-000083 filed Mar 9, 2016Research and development · Q2 FY2016: $115M · 10-Q 0000936395-16-000104 filed Jun 8, 2016Research and development · Q3 FY2016: $117M · 10-Q 0000936395-16-000115 filed Sep 7, 2016Research and development · Q4 FY2016: $112M · derived · 10-K 0000936395-17-000064 filed Dec 22, 2017Research and development · Q1 FY2017: $117M · 10-Q 0000936395-17-000020 filed Mar 8, 2017Research and development · Q2 FY2017: $122M · 10-Q 0000936395-17-000038 filed Jun 7, 2017Research and development · Q3 FY2017: $118M · 10-Q 0000936395-17-000051 filed Sep 7, 2017Research and development · Q4 FY2017: $119M · derived · 10-K 0000936395-18-000048 filed Dec 21, 2018Research and development · Q1 FY2018: $119M · 10-Q 0000936395-18-000013 filed Mar 7, 2018Research and development · Q2 FY2018: $117M · 10-Q 0000936395-18-000024 filed Jun 6, 2018Research and development · Q3 FY2018: $121M · 10-Q 0000936395-18-000037 filed Sep 5, 2018Research and development · Q4 FY2018: $135M · derived · 10-K 0000936395-20-000042 filed Dec 18, 2020Research and development · Q1 FY2019: $129M · 10-Q 0000936395-19-000010 filed Mar 11, 2019Research and development · Q2 FY2019: $138M · 10-Q 0000936395-19-000021 filed Jun 12, 2019Research and development · Q3 FY2019: $140M · 10-Q 0000936395-19-000040 filed Sep 11, 2019Research and development · Q4 FY2019: $142M · derived · 10-K 0000936395-20-000042 filed Dec 18, 2020Research and development · Q1 FY2020: $131M · 10-Q 0000936395-20-000011 filed Mar 11, 2020Research and development · Q2 FY2020: $132M · 10-Q 0000936395-20-000028 filed Jun 10, 2020Research and development · Q3 FY2020: $130M · 10-Q 0000936395-20-000036 filed Sep 9, 2020Research and development · Q4 FY2020: $137M · derived · 10-K 0000936395-21-000054 filed Dec 17, 2021Research and development · Q1 FY2021: $133M · 10-Q 0000936395-21-000010 filed Mar 10, 2021Research and development · Q2 FY2021: $110M · 10-Q 0000936395-21-000034 filed Jun 9, 2021Research and development · Q3 FY2021: $146M · 10-Q 0000936395-21-000040 filed Sep 8, 2021Research and development · Q4 FY2021: $147M · derived · 10-K 0000936395-22-000065 filed Dec 16, 2022Research and development · Q1 FY2022: $148M · 10-Q 0000936395-22-000029 filed Mar 9, 2022Research and development · Q2 FY2022: $159M · 10-Q 0000936395-22-000045 filed Jun 8, 2022Research and development · Q3 FY2022: $150M · 10-Q 0000936395-22-000053 filed Sep 7, 2022Research and development · Q4 FY2022: $167M · derived · 10-K 0000936395-23-000044 filed Dec 15, 2023Research and development · Q1 FY2023: $182M · 10-Q 0000936395-23-000014 filed Mar 8, 2023Research and development · Q2 FY2023: $190M · 10-Q 0000936395-23-000027 filed Jun 7, 2023Research and development · Q3 FY2023: $189M · 10-Q 0000936395-23-000034 filed Sep 6, 2023Research and development · Q4 FY2023: $189M · derived · 10-K 0000936395-24-000044 filed Dec 20, 2024Research and development · Q1 FY2024: $187M · 10-Q 0000936395-24-000008 filed Mar 7, 2024Research and development · Q2 FY2024: $195M · 10-Q 0000936395-24-000025 filed Jun 6, 2024Research and development · Q3 FY2024: $189M · 10-Q 0000936395-24-000032 filed Sep 4, 2024Research and development · Q4 FY2024: $196M · derived · 10-K 0001628280-25-056698 filed Dec 12, 2025Research and development · Q1 FY2025: $193M · 10-Q 0000936395-25-000011 filed Mar 12, 2025Research and development · Q2 FY2025: $215M · 10-Q 0000936395-25-000025 filed Jun 5, 2025Research and development · Q3 FY2025: $212M · 10-Q 0000936395-25-000041 filed Sep 4, 2025Research and development · Q4 FY2025: $229M · derived · 10-K 0001628280-25-056698 filed Dec 12, 2025Research and development · Q1 FY2026: $221M · 10-Q 0001628280-26-015152 filed Mar 5, 2026Research and development · Q2 FY2026: $238M · 10-Q 0001628280-26-040767 filed Jun 4, 2026Research and development · Q3 FY2026: $237M · 10-Q 0001628280-26-060361 filed Sep 3, 2026189a237108Q1 FY2016Q3 FY2026Q4 FY2023
$MResearch and development · Q4 FY2022: $167M · derived · 10-K 0000936395-23-000044 filed Dec 15, 2023Research and development · Q1 FY2023: $182M · 10-Q 0000936395-23-000014 filed Mar 8, 2023Research and development · Q2 FY2023: $190M · 10-Q 0000936395-23-000027 filed Jun 7, 2023Research and development · Q3 FY2023: $189M · 10-Q 0000936395-23-000034 filed Sep 6, 2023Research and development · Q4 FY2023: $189M · derived · 10-K 0000936395-24-000044 filed Dec 20, 2024Research and development · Q1 FY2024: $187M · 10-Q 0000936395-24-000008 filed Mar 7, 2024Research and development · Q2 FY2024: $195M · 10-Q 0000936395-24-000025 filed Jun 6, 2024Research and development · Q3 FY2024: $189M · 10-Q 0000936395-24-000032 filed Sep 4, 2024189a189167a195Q4 FY2022Q3 FY2024Q4 FY2023
Q4 FY2023
189a$M
derived
All values (43)
PeriodValue ($M)Status
Q3 FY2026237reported
Q2 FY2026238reported
Q1 FY2026221reported
Q4 FY2025229derived
Q3 FY2025212reported
Q2 FY2025215reported
Q1 FY2025193reported
Q4 FY2024196derived
Q3 FY2024189reported
Q2 FY2024195reported
Q1 FY2024187reported
Q4 FY2023189derived
Q3 FY2023189reported
Q2 FY2023190reported
Q1 FY2023182reported
Q4 FY2022167derived
Q3 FY2022150reported
Q2 FY2022159reported
Q1 FY2022148reported
Q4 FY2021147derived
Q3 FY2021146reported
Q2 FY2021110reported
Q1 FY2021133reported
Q4 FY2020137derived
Q3 FY2020130reported
Q2 FY2020132reported
Q1 FY2020131reported
Q4 FY2019142derived
Q3 FY2019140reported
Q2 FY2019138reported
Q1 FY2019129reported
Q4 FY2018135derived
Q3 FY2018121reported
Q2 FY2018117reported
Q1 FY2018119reported
Q4 FY2017119derived
Q3 FY2017118reported
Q2 FY2017122reported
Q1 FY2017117reported
Q4 FY2016112derived
Q3 FY2016117reported
Q2 FY2016115reported
Q1 FY2016108reported

CSV with all sources · Technical ID: rnd

More metrics for Ciena

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Operating income by segment

Gross profit by segment

Sources & calculation
Value
$189M (derived)
Period
Q4 FY2023, ended Oct 28, 2023 · quarterly value (3 months, not cumulative)
Calculation
Q4 = fiscal year − 9 months cumulative = 751M − 561M = $189M (FY value from 10-K 0000936395-24-000044; 9-month value from the Q3-10-Q)
Source
10-K, filed Dec 20, 2024 · 0000936395-24-000044
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$189MDec 20, 202410-K 0000936395-24-000044derived · confidence 1. · current